Pediatric Neuroblastoma Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Oct 2018| TMR1004A| Transparency

Report Highlights

Pediatric Neuroblastoma Treatment Market - Overview

This report by Transparency Market Research analyzes the global pediatric neuroblastoma treatment market for the period between 2018 and 2026. An in-depth market assessment has been made, which offers readers accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various products as well as new players planning to enter this market.

The global pediatric neuroblastoma treatment market has been studied for the forecast period from 2018 to 2026. For research, 2017 has been considered as the base year and 2016 as the historical year. The market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape by major players operating in this market along with their shares (value %) of the global pediatric neuroblastoma treatment market for 2017. The report also provides detailed company profiles of emerging market players operating in the global market.

The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the global pediatric neuroblastoma treatment market. These factors are likely to aid stakeholders establish a strong foothold in the global market. Furthermore, the overview section comprises market attractiveness analysis, global market analysis, and forecast of the global pediatric neuroblastoma treatment market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and countries to identify the most attractive market.

Scope

The global pediatric neuroblastoma treatment market has been segmented based therapy type and distribution channel. In terms of therapy type, the global market has been classified into immunotherapy, chemotherapy, and others. Based on distribution channel, the global pediatric neuroblastoma treatment market has been categorized into hospital pharmacies and retail pharmacies & drug stores.

In terms of region, the global pediatric neuroblastoma treatment market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, and Australia & New Zealand has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the global pediatric neuroblastoma treatment market in various regions has been provided in this section.

The report provides a detailed outline/blueprint of the global pediatric neuroblastoma treatment market that is expected to assist new companies establish their presence and expanding their share in the market. The report concludes with the company profile section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments.

Competitive Landscape

Major players operating in the global pediatric neuroblastoma treatment market include United Therapeutics Corporation, APEIRON Biologics AG, Baxter, Cellectar Biosciences, Inc., Pfizer, Inc., MacroGenics, Inc., and Bayer AG.

The global pediatric neuroblastoma treatment market has been segmented into:

Global Pediatric Neuroblastoma Treatment Market, by Therapy Type
Immunotherapy
Chemotherapy
Others


Global Pediatric Neuroblastoma Treatment Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores


Global Pediatric Neuroblastoma Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Rest of Europe
Rest of the World

  • Table 1 : List of acronyms used in the report
  • Table 2 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 3 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 4 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 5 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 6 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 7 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 8 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 9 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 10 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 11 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 12 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 13 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 14 : Global Pediatric Neuroblastoma Treatment Market: Pipeline Analysis
  • Table 15 : Global Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Therapy Type, 2016–2026
  • Table 16 : Global Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 17 : Global Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Region, 2016–2026
  • Table 18 : North America Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
  • Table 19 : North America Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Therapy Type, 2016–2026
  • Table 20 : North America Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 21 : Europe Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 22 : Europe Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Therapy Type, 2016–2026
  • Table 23 : Europe Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 24 : Rest of the World Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Therapy Type, 2016–2026
  • Table 25 : Rest of the World Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Figure 1 : Global Pediatric Neuroblastoma Treatment Market
  • Figure 2 : Global Pediatric Neuroblastoma Treatment Market Size (US$ Mn), by Therapy Type, 2017
  • Figure 3 : Global Pediatric Neuroblastoma Treatment Market Segments with Leading Market Share (%), 2017
  • Figure 4 : Global Pediatric Neuroblastoma Treatment Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 5 : Global Pediatric Neuroblastoma Treatment Market Value Share (%), by Therapy Type, 2017
  • Figure 6 : Global Pediatric Neuroblastoma Treatment Market Value Share (%), by Distribution Channel, 2017
  • Figure 7 : Global Pediatric Neuroblastoma Treatment Market Value Share (%), by Region, 2017
  • Figure 8 : Key Industry Events
  • Figure 9 : Porter’s Five Forces Analysis
  • Figure 10 : Epidemiology of Neuroblastoma
  • Figure 11 : Epidemiology of Neuroblastoma: Numbers of Annual New Neuroblastoma Cases in Key Markets
  • Figure 12 : Epidemiology of Neuroblastoma Key Research Findings
  • Figure 13 : Epidemiology of Neuroblastoma, by Country
  • Figure 14 : Epidemiology of Neuroblastoma, by Country
  • Figure 15 : Epidemiology of Neuroblastoma, by Country
  • Figure 16 : Key Unmet Needs in the Pediatric Neuroblastoma Treatment Market
  • Figure 17 : Global Pediatric Neuroblastoma Treatment Market: Rate of Metastasis to the Brain
  • Figure 18 : Global Pediatric Neuroblastoma Treatment Market: Rate of Metastasis to the Brain
  • Figure 19 : Global Pediatric Neuroblastoma Treatment Market: Neuroblastoma Relapse/Refractory cases
  • Figure 20 : Global Pediatric Neuroblastoma Treatment Market: Neuroblastoma Relapse/Refractory cases
  • Figure 21 : Global Pediatric Neuroblastoma Treatment Market: Utilization of MIBG-131
  • Figure 22 : Global Pediatric Neuroblastoma Treatment Market: Utilization of MIBG-131
  • Figure 23 : Global Pediatric Neuroblastoma Treatment Market Value Share (%), by Therapy Type, 2017 and 2026
  • Figure 24 : Global Pediatric Neuroblastoma Treatment Market Attractiveness, by Therapy Type, 2018–2026
  • Figure 25 : Global Pediatric Neuroblastoma Treatment Market Revenue (US$ Mn) Forecast, by Immunotherapy, 2016–2026
  • Figure 26 : Global Pediatric Neuroblastoma Treatment Market Revenue (US$ Mn) Forecast, by Chemotherapy, 2016–2026
  • Figure 27 : Global Pediatric Neuroblastoma Treatment Market Revenue (US$ Mn) Forecast, by Others, 2016–2026
  • Figure 28 : Global Pediatric Neuroblastoma Treatment Market Value Share (%), by Distribution Channel, 2017 and 2026
  • Figure 29 : Global Pediatric Neuroblastoma Treatment Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 30 : Global Pediatric Neuroblastoma Treatment Market Revenue (US$ Mn) Forecast, by Hospital Pharmacies, 2016–2026
  • Figure 31 : Global Pediatric Neuroblastoma Treatment Market Revenue (US$ Mn) Forecast, by Retail Pharmacies & Drug Stores, 2016–2026
  • Figure 32 : Global Pediatric Neuroblastoma Treatment Market Value Share (%), by Region, 2017 and 2026
  • Figure 33 : Global Pediatric Neuroblastoma Treatment Market Attractiveness, by Region, 2018–2026
  • Figure 34 : North America Pediatric Neuroblastoma Treatment Market Revenue (US$ Mn) forecast, 2016–2026
  • Figure 35 : North America Pediatric Neuroblastoma Treatment Market Value Share (%), by Country, 2017 and 2026
  • Figure 36 : North America Pediatric Neuroblastoma Treatment Market Attractiveness, by Country, 2018–2026
  • Figure 37 : North America Pediatric Neuroblastoma Treatment Market Value Share (%), by Therapy Type, 2017 and 2026
  • Figure 38 : North America Pediatric Neuroblastoma Treatment Market Attractiveness, by Therapy Type, 2018–2026
  • Figure 39 : North America Pediatric Neuroblastoma Treatment Market Value Share (%), by Distribution Channel, 2017 and 2026
  • Figure 40 : North America Pediatric Neuroblastoma Treatment Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 41 : Europe Pediatric Neuroblastoma Treatment Market Revenue (US$ Mn) Forecast, 2016–2026
  • Figure 42 : Europe Pediatric Neuroblastoma Treatment Market Value Share (%), by Country/Sub-region, 2017 and 2026
  • Figure 43 : Europe Pediatric Neuroblastoma Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 44 : Europe Pediatric Neuroblastoma Treatment Market Value Share (%), by Therapy Type, 2017 and 2026
  • Figure 45 : Europe Pediatric Neuroblastoma Treatment Market Attractiveness, by Therapy Type, 2018–2026
  • Figure 46 : Europe Pediatric Neuroblastoma Treatment Market Value Share (%), by Distribution Channel, 2017 and 2026
  • Figure 47 : Europe Pediatric Neuroblastoma Treatment Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 48 : Rest of the World Pediatric Neuroblastoma Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 49 : Rest of the World Pediatric Neuroblastoma Treatment Market Value Share (%), by Therapy Type, 2017 and 2026
  • Figure 50 : Rest of the World Pediatric Neuroblastoma Treatment Market Attractiveness, by Therapy Type, 2018–2026
  • Figure 51 : Rest of the World Pediatric Neuroblastoma Treatment Market Value Share (%), by Distribution Channel, 2017 and 2026
  • Figure 52 : Rest of the World Pediatric Neuroblastoma Treatment Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 53 : United Therapeutics Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 54 : United Therapeutics Corporation Net sales of Unituxin (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 55 : United Therapeutics Corporation Breakdown of Net Sales, by Product, 2017
  • Figure 56 : United Therapeutics Corporation Research and Development Cost (US$ Mn), 2015–2017
  • Figure 57 : United Therapeutics Corporation: SWOT Analysis
  • Figure 58 : MacroGenics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 59 : MacroGenics, Inc. Net sales of Unituxin (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 60 : MacroGenics, Inc. Net sales (US$ Mn) by key brands
  • Figure 61 : MacroGenics, Inc. Research and Development Cost (US$ Mn), 2015–2017
  • Figure 62 : MacroGenics, Inc.: SWOT Analysis
  • Figure 63 : APEIRON Biologics AG: SWOT Analysis
  • Figure 64 : Baxter Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 65 : Baxter Breakdown of Net Sales (%), by Region, 2017
  • Figure 66 : Baxter pipeline of generic products, 2016–2020
  • Figure 67 : Baxter: SWOT Analysis
  • Figure 68 : Pfizer Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 69 : Pfizer Inc. R&D Expenses (US$ Mn), 2014–2017
  • Figure 70 : Pfizer Inc.: SWOT Analysis
  • Figure 71 : Cellectar Biosciences, Inc. Research and Development Cost (US$ Mn) and Y-o-Y Growth (%), 2016–2017
  • Figure 72 : Cellectar Biosciences, Inc.: SWOT Analysis
  • Figure 73 : Bayer Group Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2017
  • Figure 74 : Bayer Group Breakdown of Net Sales (%), by Region, 2017
  • Figure 75 : Bayer Group Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 76 : Bayer Group: SWOT Analysis

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report